{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:59:48Z","timestamp":1769821188265,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bioorg.2023.106830","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:37:36Z","timestamp":1693924656000},"page":"106830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease"],"prefix":"10.1016","volume":"140","author":[{"given":"Wandong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kairui","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengbiao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106830_b0005","unstructured":"World Health Organization Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/ (accessed Jun 30, 2022)."},{"key":"10.1016\/j.bioorg.2023.106830_b0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/joim.13478","article-title":"Advances in the Omicron variant development","volume":"292","author":"Antonio","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bioorg.2023.106830_b0015","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/22221751.2022.2072773","article-title":"Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection, Emerg","volume":"11","author":"Jing","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bioorg.2023.106830_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Ben","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2023.106830_b0025","first-page":"2","article-title":"Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2","volume":"60","author":"Hailei","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2023.106830_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Cody","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2023.106830_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"Philip","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2023.106830_b0040","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Daniel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106830_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-020-00335-z","article-title":"SARS-CoV-2: the many pros of targeting PLpro","volume":"5","author":"Christopher","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2023.106830_b0050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Donghyuk","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106830_b0055","article-title":"Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?","volume":"215","author":"Sk","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0060","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","article-title":"Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease","volume":"65","author":"Haozhou","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0065","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41590-021-01035-8","article-title":"Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection","volume":"22","author":"Deeksha","year":"2021","journal-title":"Nat. Immunol."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106830_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109754","article-title":"A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease","volume":"36","author":"Patchett","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2023.106830_b0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Jerzy","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106830_b0080","article-title":"Conserved coronavirus proteins as targets of broad-spectrum antivirals","volume":"204","author":"Cleber","year":"2022","journal-title":"Antiviral Res."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106830_b0085","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/jmv.25909","article-title":"Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene","volume":"92","author":"Kasibhatla","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bioorg.2023.106830_b0090","first-page":"3879","article-title":"SARS-CoV-2 cell entry and targeted antiviral development","volume":"12","author":"Zinuo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2023.106830_b0095","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acs.jmedchem.0c01140","article-title":"Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities","volume":"65","author":"Rolando","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0100","first-page":"16119","article-title":"A noncovalent class of papain-like protease\/ deubiquitinase inhibitors blocks SARS virus replication","volume":"42","author":"Kiira","year":"2008","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2023.106830_b0105","first-page":"877","article-title":"High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors, Protein","volume":"11","author":"Yao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2023.106830_b0110","first-page":"876","article-title":"Design and Evaluation of a Novel Peptide\u2212Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease","volume":"1","author":"Na","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0115","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay","volume":"7","author":"Chunlong","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2023.106830_b0120","first-page":"237","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"1","author":"Xiaopan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2023.106830_b0125","first-page":"448","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"Commun12","author":"Ziyang","year":"2021","journal-title":"Nat."},{"key":"10.1016\/j.bioorg.2023.106830_b0130","first-page":"2940","article-title":"Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity","volume":"4","author":"Zhengnan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0135","article-title":"Drug repurposing for COVID-19: Approaches, challenges and promising candidates","volume":"228","author":"Yan","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2023.106830_b0140","doi-asserted-by":"crossref","unstructured":"Nicholas C. K. V., Anna H., Brent D. G. P., Geoffrey M., Daniel R., Megan C., Luka B., Patrick H., Evert H., Nina G. S., Pal S., Ann-Sofie J., Thomas H. NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine, Cancer Res. 18 (2016) 5501\u20135511. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0584.","DOI":"10.1158\/0008-5472.CAN-16-0584"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106830_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103213","article-title":"6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro","volume":"24","author":"Swaim","year":"2021","journal-title":"iScience"},{"issue":"36","key":"10.1016\/j.bioorg.2023.106830_b0150","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/D0SC02646H","article-title":"Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors","volume":"11","author":"Sargsyan","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2023.106830_b0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Zhenming","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106830_b0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijsu.2020.10.018","article-title":"Ebselen, a new candidate therapeutic against SARS-CoV-2","volume":"84","author":"Haritha","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bioorg.2023.106830_b0165","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106830_b0170","doi-asserted-by":"crossref","unstructured":"Zmudzinski M, Rut W, Olech K, Granda J, Giurg M, Burda GM, Zhang L, Sun X, Lv Z, Nayak D, Kesik BM, Olsen SK, Hilgenfeld R, Drag M. Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases-PLpro and Mpro in in vitro studies, bioRxiv (2020) 1-16. https:\/\/doi.org\/10.1101\/2020.08.30.273979.","DOI":"10.1101\/2020.08.30.273979"},{"key":"10.1016\/j.bioorg.2023.106830_b0175","first-page":"2866","article-title":"Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors","volume":"4","author":"Sarah","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0180","first-page":"e202100582","article-title":"Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease","volume":"4","author":"Siegfried","year":"2022","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0185","doi-asserted-by":"crossref","unstructured":"Osipiuk J, Tesar C, Endres M, Maltseva N, Joachimiak A. The crystal structure of Papain-Like Protease of SARS CoV-2, C111S mutant, in complex with ebselen, PDB DOI:10.2210\/pdb7M1Y\/pdb.","DOI":"10.2210\/pdb7m1y\/pdb"},{"key":"10.1016\/j.bioorg.2023.106830_b0190","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1039\/C5CC02594J","article-title":"Ebselen as a potent covalent inhibitor of New Delhi metallo-\u03b2-lactamase (NDM-1)","volume":"51","author":"Jiachi","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106830_b0195","first-page":"237","article-title":"Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic, Free Radical","volume":"127","author":"Xiaoyuan","year":"2018","journal-title":"Bio. Med."},{"key":"10.1016\/j.bioorg.2023.106830_b0200","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1039\/C8CC04258F","article-title":"Target discovery of ebselen with a biotinylated probe","volume":"54","author":"Zhenzhen","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106830_b0205","doi-asserted-by":"crossref","unstructured":"R. A. Copeland, Lead Optimization and Structure-activity Relationships for Reversible Inhibitors, in R. A. Copeland, Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists, John Wiley & Sons Inc., Hoboken, 2013, pp.186.","DOI":"10.1002\/9781118540398"},{"key":"10.1016\/j.bioorg.2023.106830_b0210","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/pmic.201100649","article-title":"An accurate proteomic quantification method: Fluorescence labeling absolute quantification (FLAQ) using multidimensional liquid chromatography and tandem mass spectrometry","volume":"12","author":"Junyan","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.bioorg.2023.106830_b0215","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1039\/C8CC01067F","article-title":"A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-b-lactamases","volume":"54","author":"Cheng","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106830_b0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bioorg.2018.11.035","article-title":"Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-\u03b2-lactamase-1 in vitro and in vivo","volume":"84","author":"Jianpeng","year":"2019","journal-title":"Bioorganic Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0225","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","article-title":"Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models","volume":"65","author":"Yingjun","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106830_b0230","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1021\/acs.jmedchem.1c00566","article-title":"Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors","volume":"65","author":"Sarah","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823004911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823004911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:54:12Z","timestamp":1758617652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823004911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S0045206823004911"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106830","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106830"}}